107 related articles for article (PubMed ID: 12081602)
1. T-cell antigenic determinants within hepatitis C virus nonstructural protein 3 and cytokine production profiles in hepatitis C.
Pan CH; Yang PM; Hwang LH; Kao SF; Chen PJ; Chiang BL; Chen DS
J Viral Hepat; 2002 Jul; 9(4):258-64. PubMed ID: 12081602
[TBL] [Abstract][Full Text] [Related]
2. Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection.
Tsai SL; Chen PJ; Hwang LH; Kao JH; Huang JH; Chang TH; Chen DS
J Hepatol; 1994 Sep; 21(3):403-11. PubMed ID: 7530738
[TBL] [Abstract][Full Text] [Related]
3. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
[TBL] [Abstract][Full Text] [Related]
4. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
Zhu F; Eckels DD
Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
[TBL] [Abstract][Full Text] [Related]
5. Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection.
Cusick MF; Yang M; Gill JC; Eckels DD
Hum Immunol; 2011 May; 72(5):379-85. PubMed ID: 21377503
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of NS3 protein-specific T-cell clones from a patient with chronic hepatitis C.
Chiang BL; Yang PM; Hwang LH; Wang JM; Kao SF; Pan CH; Chi WK; Chen PJ; Chen DS
J Biomed Sci; 1998; 5(4):290-6. PubMed ID: 9691222
[TBL] [Abstract][Full Text] [Related]
7. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
[TBL] [Abstract][Full Text] [Related]
8. Antigenic heterogeneity of the hepatitis C virus NS5A protein.
Dou XG; Talekar G; Chang J; Dai X; Li L; Bonafonte MT; Holloway B; Fields HA; Khudyakov YE
J Clin Microbiol; 2002 Jan; 40(1):61-7. PubMed ID: 11773093
[TBL] [Abstract][Full Text] [Related]
9. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK
Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415
[TBL] [Abstract][Full Text] [Related]
10. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.
Li W; Krishnadas DK; Li J; Tyrrell DL; Agrawal B
J Immunol; 2006 May; 176(10):6065-75. PubMed ID: 16670315
[TBL] [Abstract][Full Text] [Related]
11. In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation.
Eckels DD; Tabatabail N; Bian TH; Wang H; Muheisen SS; Rice CM; Yoshizawa K; Gill J
Hum Immunol; 1999 Mar; 60(3):187-99. PubMed ID: 10321955
[TBL] [Abstract][Full Text] [Related]
12. Characterization of monoclonal antibodies against hepatitis C virus nonstructural protein 3: different antigenic determinants from human B cells.
Ou-Yang P; Chiang BL; Hwang LH; Chen YG; Yang PM; Chi WK; Chen PJ; Chen DS
J Med Virol; 1999 Apr; 57(4):345-50. PubMed ID: 10089044
[TBL] [Abstract][Full Text] [Related]
13. DNA immunization efficiently targets conserved functional domains of protease and ATPase/helicase of nonstructural 3 protein (NS3) of human hepatitis C virus.
Isaguliants MG; Petrakova NV; Mokhonov VV; Pokrovskaya K; Suzdaltzeva YG; Krivonos AV; Zaberezhny AD; Garaev MM; Smirnov VD; Nordenfelt E
Immunol Lett; 2003 Jul; 88(1):1-13. PubMed ID: 12853154
[TBL] [Abstract][Full Text] [Related]
14. Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C.
Yang PM; Hwang LH; Lai MY; Huang WL; Chu YD; Chi WK; Chiang BL; Kao JH; Chen PJ; Chen DS
Clin Exp Immunol; 1995 Aug; 101(2):272-7. PubMed ID: 7544249
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees.
Shata MT; Anthony DD; Carlson NL; Andrus L; Brotman B; Tricoche N; McCormack P; Prince A
J Viral Hepat; 2002 Nov; 9(6):400-10. PubMed ID: 12431201
[TBL] [Abstract][Full Text] [Related]
16. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.
Haller AA; Lauer GM; King TH; Kemmler C; Fiolkoski V; Lu Y; Bellgrau D; Rodell TC; Apelian D; Franzusoff A; Duke RC
Vaccine; 2007 Feb; 25(8):1452-63. PubMed ID: 17098335
[TBL] [Abstract][Full Text] [Related]
17. Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection.
Zhang ZX; Chen M; Sönnerborg A; Sällberg M
Clin Diagn Lab Immunol; 1994 May; 1(3):290-4. PubMed ID: 7496964
[TBL] [Abstract][Full Text] [Related]
18. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
[TBL] [Abstract][Full Text] [Related]
19. Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response.
Rollier C; Depla E; Drexhage JA; Verschoor EJ; Verstrepen BE; Fatmi A; Brinster C; Fournillier A; Whelan JA; Whelan M; Jacobs D; Maertens G; Inchauspé G; Heeney JL
J Virol; 2004 Jan; 78(1):187-96. PubMed ID: 14671100
[TBL] [Abstract][Full Text] [Related]
20. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
